{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:55:04Z","timestamp":1792047304345,"version":"4.4.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jns.2008.04.020","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T20:24:55Z","timestamp":1216239895000},"page":"171-173","source":"Crossref","is-referenced-by-count":33,"title":["Effective immunosuppressant therapy with cyclophosphamide and corticosteroids in paraneoplastic cerebellar degeneration"],"prefix":"10.1016","volume":"272","author":[{"given":"Jan","family":"Th\u00f6ne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hohaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Erbguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2008.04.020_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.04.020_bib2","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.coi.2004.07.009","article-title":"Neuroimmunology of the paraneoplastic neurological degenerations","volume":"16","author":"Roberts","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jns.2008.04.020_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Management of paraneoplastic neurological syndromes: report of an EFNS Task Force","volume":"13","author":"Vedeler","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.04.020_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/WNL.55.5.713","article-title":"Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies","volume":"55","author":"Rojas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.04.020_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2008.04.020_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(64)91694-0","article-title":"Serologic findings in carcinomatous neuromyopathy","volume":"88","author":"Wilkinson","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2008.04.020_bib7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/brain\/88.3.529","article-title":"Immunofluorescent detection of antibodies against neurons in sensory carcinomatous neuropathy","volume":"88","author":"Wilkinson","year":"1965","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.04.020_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archneur.1976.00500090066014","article-title":"Cerebellar degeneration with Hodgkin disease. An immunological study","volume":"33","author":"Trotter","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2008.04.020_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410140603","article-title":"Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma","volume":"14","author":"Greenlee","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.04.020_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-510X(00)00353-1","article-title":"Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report","volume":"178","author":"Mowzoon","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.04.020_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11060-006-9198-x","article-title":"Neurological improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody","volume":"81","author":"Phuphanich","year":"2007","journal-title":"J Neuroncol"},{"key":"10.1016\/j.jns.2008.04.020_bib12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1272\/jnms.71.412","article-title":"A pre-senile case of limbic encephalitis and cerebellar degeneration, with subacute onset of progressive dementia","volume":"71","author":"Mori","year":"2004","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.jns.2008.04.020_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.410240413","article-title":"Paraneoplastic cerebellar degeneration: clinic and neurologic correlations","volume":"24","author":"Anderson","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.04.020_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2006.01476.x","article-title":"Guidelines for the treatment of autoimmune neuromuscular transmission disorders","volume":"13","author":"Skeie","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2008.04.020_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1040-8428(03)00100-8","article-title":"Ovarian cancer in the elderly","volume":"49","author":"Pignata","year":"2004","journal-title":"Crit Rev Oncol\/Hematol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T01:59:16Z","timestamp":1545875956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0022510X08002001"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.04.020","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}